GlassScriptPhysician profile
Heather Horne
NPI 1821616426
$995.09
in general payments reported to CMS, 2019-2025
10 companies · $707 in 2025
The $707 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.76 · 2022: $22.38 · 2023: $84.69 · 2024: $156 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $225.01 | 2025 | |
| Paratek Pharmaceuticals, INC. | $221.01 | 2023-2025 | Nuzyra |
| Smith+Nephew, INC. | $152.58 | 2024-2025 | Grafix Pl, Collagenase Santyl, Oasis |
| Reapplix INC. | $141.67 | 2025 | 3c Patch Kit - Box |
| Convatec INC. | $125.00 | 2025 | |
| Hartmann USA, INC. | $34.53 | 2025 | Zetuvit Plus 10x10 P10 |
| Insmed, INC. | $34.29 | 2021-2022 | |
| Melinta Therapeutics, LLC | $24.85 | 2023 | Vabomere, Orbactiv, Kimyrsa |
| Surgenex LLC | $23.30 | 2025 | Surgraft, Pellograft, Surmatrix |
| Merck Sharp & Dohme LLC | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Horne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.